These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 22611246)

  • 1. Comment on "Frequency of epitope-specific naive CD4+ T cells correlates with immunodominance in the human memory repertoire".
    Ascough S; Ingram RJ; Metan G; Maillere B; Doganay M; Ozkul Y; Kim LU; Ballie L; Moore S; Huwar TB; Sriskandan S; Altmann DM
    J Immunol; 2012 Jun; 188(11):5205-6; author reply 5206. PubMed ID: 22611246
    [No Abstract]   [Full Text] [Related]  

  • 2. Frequency of epitope-specific naive CD4(+) T cells correlates with immunodominance in the human memory repertoire.
    Kwok WW; Tan V; Gillette L; Littell CT; Soltis MA; LaFond RB; Yang J; James EA; DeLong JH
    J Immunol; 2012 Mar; 188(6):2537-44. PubMed ID: 22327072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The immunodominant CD8 T cell response to the human cytomegalovirus tegument phosphoprotein pp65(495-503) epitope critically depends on CD4 T cell help in vaccinated HLA-A*0201 transgenic mice.
    Reiser M; Wieland A; Plachter B; Mertens T; Greiner J; Schirmbeck R
    J Immunol; 2011 Sep; 187(5):2172-80. PubMed ID: 21810614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Tumor Antigen Cyclin B1 Hosts Multiple CD4 T Cell Epitopes Differently Recognized by Pre-Existing Naive and Memory Cells in Both Healthy and Cancer Donors.
    Chevaleyre C; Benhamouda N; Favry E; Fabre E; Mhoumadi A; Nozach H; Marcon E; Cosler G; Vinatier E; Oudard S; Hans S; Le Pimpec-Barthes F; Bats AS; Castelli FA; Tartour E; Maillère B
    J Immunol; 2015 Aug; 195(4):1891-901. PubMed ID: 26136431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T cell immunodominance and maintenance of memory regulated by unexpectedly cross-reactive pathogens.
    Brehm MA; Pinto AK; Daniels KA; Schneck JP; Welsh RM; Selin LK
    Nat Immunol; 2002 Jul; 3(7):627-34. PubMed ID: 12055626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD4(+) T cells from healthy subjects and colon cancer patients recognize a carcinoembryonic antigen-specific immunodominant epitope.
    Campi G; Crosti M; Consogno G; Facchinetti V; Conti-Fine BM; Longhi R; Casorati G; Dellabona P; Protti MP
    Cancer Res; 2003 Dec; 63(23):8481-6. PubMed ID: 14679013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Of cats and men: immunodominance and the role of HLA-DP/DQ.
    Larché M
    Clin Exp Allergy; 2008 Nov; 38(11):1709-11. PubMed ID: 19489915
    [No Abstract]   [Full Text] [Related]  

  • 8. Deciphering and predicting CD4+ T cell immunodominance of influenza virus hemagglutinin.
    Cassotta A; Paparoditis P; Geiger R; Mettu RR; Landry SJ; Donati A; Benevento M; Foglierini M; Lewis DJM; Lanzavecchia A; Sallusto F
    J Exp Med; 2020 Oct; 217(10):. PubMed ID: 32644114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selection of immunodominant epitopes during antigen processing is hierarchical.
    Sadegh-Nasseri S; Kim A
    Mol Immunol; 2019 Sep; 113():115-119. PubMed ID: 30146122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Major contribution of codominant CD8 and CD4 T cell epitopes to the human cytomegalovirus-specific T cell repertoire.
    Nastke MD; Herrgen L; Walter S; Wernet D; Rammensee HG; Stevanović S
    Cell Mol Life Sci; 2005 Jan; 62(1):77-86. PubMed ID: 15619009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative study of GAD65-specific CD4+ T cells in healthy and type 1 diabetic subjects.
    Danke NA; Yang J; Greenbaum C; Kwok WW
    J Autoimmun; 2005 Dec; 25(4):303-11. PubMed ID: 16249070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of novel HLA-DR11-restricted HCV epitopes reveals both qualitative and quantitative differences in HCV-specific CD4+ T cell responses in chronically infected and non-viremic patients.
    Godkin A; Jeanguet N; Thursz M; Openshaw P; Thomas H
    Eur J Immunol; 2001 May; 31(5):1438-46. PubMed ID: 11465100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Broadly reactive human CD4
    Cassotta A; Goldstein JD; Durini G; Jarrossay D; Baggi Menozzi F; Venditti M; Russo A; Falcone M; Lanzavecchia A; Gagliardi MC; Latorre D; Sallusto F
    Eur J Immunol; 2021 Mar; 51(3):648-661. PubMed ID: 33226131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD4+ T lymphocytes from Anaplasma marginale major surface protein 2 (MSP2) vaccinees recognize naturally processed epitopes conserved in MSP3.
    Brown WC; Palmer GH; Brayton KA; Meeus PF; Barbet AF; Kegerreis KA; McGuire TC
    Infect Immun; 2004 Jun; 72(6):3688-92. PubMed ID: 15155686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mapping and restriction of a dominant viral CD4+ T cell core epitope by both MHC class I and MHC class II.
    Homann D; Lewicki H; Brooks D; Eberlein J; Mallet-Designé V; Teyton L; Oldstone MB
    Virology; 2007 Jun; 363(1):113-23. PubMed ID: 17320138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phenotype based approach for the immune monitoring of NY-ESO-1-specific CD4+ T cell responses in cancer patients.
    Ayyoub M; Souleimanian NE; Godefroy E; Scotto L; Hesdorffer CS; Old LJ; Valmori D
    Clin Immunol; 2006; 118(2-3):188-94. PubMed ID: 16368270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ADAMTS13
    Gilardin L; Delignat S; Peyron I; Ing M; Lone YC; Gangadharan B; Michard B; Kherabi Y; Sharma M; Pashov A; Latouche JB; Hamieh M; Toutirais O; Loiseau P; Galicier L; Veyradier A; Kaveri S; Maillère B; Coppo P; Lacroix-Desmazes S
    Haematologica; 2017 Nov; 102(11):1833-1841. PubMed ID: 28751567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD4+ T cell epitope discovery and rational vaccine design.
    Rosa DS; Ribeiro SP; Cunha-Neto E
    Arch Immunol Ther Exp (Warsz); 2010 Apr; 58(2):121-30. PubMed ID: 20155490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal mapping of protective CD4+ T cell responses against HCV: analysis of fluctuating dominant and subdominant HLA-DR11 restricted epitopes.
    Harcourt GC; Lucas M; Sheridan I; Barnes E; Phillips R; Klenerman P
    J Viral Hepat; 2004 Jul; 11(4):324-31. PubMed ID: 15230855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant vaccines of a CD4+ T-cell epitope promote efficient control of Paracoccidioides brasiliensis burden by restraining primary organ infection.
    Holanda RA; Muñoz JE; Dias LS; Silva LBR; Santos JRA; Pagliari S; Vieira ÉLM; Paixão TA; Taborda CP; Santos DA; Bruña-Romero O
    PLoS Negl Trop Dis; 2017 Sep; 11(9):e0005927. PubMed ID: 28938005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.